Hanmi Pharm Co Ltd (128940) — Long-term Investment Intensity
Hanmi Pharm Co Ltd (128940) has a Long-term Investment Intensity of 3.5% as of December 2019. Long-term investments of ₩67.01 Billion represent 3.5% of total assets of ₩1.91 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 128940 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hanmi Pharm Co Ltd Long-term Investment Intensity (2013–2019)
This chart shows how Hanmi Pharm Co Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 3.5%, reflecting long-term investments of ₩67.01 Billion against total assets of ₩1.91 Trillion KRW. For the complete balance sheet picture, see Hanmi Pharm Co Ltd asset portfolio.
Annual Long-term Investment Intensity for Hanmi Pharm Co Ltd (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Hanmi Pharm Co Ltd from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 128940 current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.5% | ₩67.01 Billion | ₩1.91 Trillion | ▲ +0.4 pp |
| 2018 | 3.2% | ₩53.28 Billion | ₩1.69 Trillion | ▼ -0.1 pp |
| 2017 | 3.3% | ₩54.40 Billion | ₩1.66 Trillion | ▲ +1.6 pp |
| 2016 | 1.6% | ₩26.19 Billion | ₩1.60 Trillion | ▼ -0.8 pp |
| 2015 | 2.5% | ₩42.33 Billion | ₩1.72 Trillion | ▼ -2.3 pp |
| 2014 | 4.8% | ₩49.23 Billion | ₩1.03 Trillion | ▼ -2.8 pp |
| 2013 | 7.5% | ₩66.33 Billion | ₩880.87 Billion | — |